Biohaven Enters Into Collaboration With Cove, Leading Migraine Telemedicine Platform, To Enhance Accessibility...
(WorldNews Health)

04/07/2020 Biohaven Enters Into Collaboration With Cove, Leading Migraine Telemedicine Platform, To Enhance Accessibility Of NURTECTM ODT- NURTEC ODT is the first and only anti-CGRP prescription product in the Cove telemedicine network- Cove offers migraine patients increased access to ongoing, specialized care and innovative treatments through its telemedicine platform- Telemedicine collaboration expands comprehensive NURTEC ODT patient affordability and access programs NEW HAVEN, Conn., April 7, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced a collaboration with Cove, a company providing specialized care and access to innovative treatments for...